Tracy L Rowan1, Jillian L Drouin. 1. Sports Sciences Resident, Canadian Memorial Chiropractic College, 6100 Leslie Street, Toronto, Canada.
Abstract
OBJECTIVE: Patellar tendinopathy affects a substantial proportion of athletes involved in jumping or kicking activities. Platelet rich plasma (PRP) injections may be a promising treatment used in conjunction with common traditional therapies. CLINICAL FEATURES: Patellar tendinopathy is often the result of repetitive or excessive overload on the patellar tendon. Activity modification, cryotherapy, eccentric exercises, shockwave therapy, and PRP have been indicated as treatment options during various stages of this condition. INTERVENTION AND OUTCOME: A 23 year old female, elite track and field athlete was managed for patellar tendinopathy with a combination of traditional therapeutic interventions as well as a PRP injection. This athlete returned to pre-injury level of competition six months post-injection. CONCLUSION: Emerging literature on PRP appears to be promising for patellar tendinopathy, however, it remains unclear which patients may benefit most and whether the stage of the disorder has an impact on the clinical outcome.
OBJECTIVE:Patellar tendinopathy affects a substantial proportion of athletes involved in jumping or kicking activities. Platelet rich plasma (PRP) injections may be a promising treatment used in conjunction with common traditional therapies. CLINICAL FEATURES: Patellar tendinopathy is often the result of repetitive or excessive overload on the patellar tendon. Activity modification, cryotherapy, eccentric exercises, shockwave therapy, and PRP have been indicated as treatment options during various stages of this condition. INTERVENTION AND OUTCOME: A 23 year old female, elite track and field athlete was managed for patellar tendinopathy with a combination of traditional therapeutic interventions as well as a PRP injection. This athlete returned to pre-injury level of competition six months post-injection. CONCLUSION: Emerging literature on PRP appears to be promising for patellar tendinopathy, however, it remains unclear which patients may benefit most and whether the stage of the disorder has an impact on the clinical outcome.
Authors: Mario Vetrano; Anna Castorina; Maria Chiara Vulpiani; Rossella Baldini; Antonio Pavan; Andrea Ferretti Journal: Am J Sports Med Date: 2013-02-13 Impact factor: 6.202
Authors: Marieke de Mos; Anna E van der Windt; Holger Jahr; Hans T M van Schie; Harrie Weinans; Jan A N Verhaar; Gerjo J V M van Osch Journal: Am J Sports Med Date: 2008-03-07 Impact factor: 6.202
Authors: Marni Wesner; Terry Defreitas; Heather Bredy; Louisa Pothier; Ziling Qin; Ashley B McKillop; Douglas P Gross Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240